MedPath
NMPA Approval

Drospirenone and Ethinylestradiol Tablets

国药准字HJ20170317

March 21, 2022

H20170317

Drug Information

屈螺酮炔雌醇片

优思明

片剂

每片含炔雌醇0.03mg和屈螺酮3mg

化学药品

March 21, 2022

March 20, 2027

Company Information

Applicant Company

875 Pacific Highway PYMBLE NSW 2073,Australia

Manufacturing Company

bayer weimar gmbh & co. kg

Doebereinerstrasse 20 99427 Weimar, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

屈螺酮炔雌醇片 - NMPA 批准文号 | MedPath